Could a Once-Daily pill replace needles for kids with blood clots?

NCT ID NCT07618988

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether the blood thinner pill rivaroxaban works as well as standard injections (enoxaparin) in children aged 6 months to 18 years with deep vein clots. Sixty children were randomly assigned to either the pill or injections for 3 months. The main goal was to see how well the clots cleared up on repeat imaging.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

rivaroxaban

What this could lead to

If successful, this could offer a simpler oral treatment option for children with deep vein clots, potentially replacing daily injections.

What could go wrong

This is a small, single-center trial with only 60 children, so results may not apply broadly. Bleeding risk remains a concern with any blood thinner.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC VENOUS THROMBOEMBOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ain Shams University Children's Hospital

    Cairo, 11566, Egypt